Patents by Inventor Doo-il Jeoung

Doo-il Jeoung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells
    Patent number: 10239924
    Abstract: A peptide having eight amino acid sequences derived from cancer-associated gene (CAGE) is described which retains anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug resistant cancer cells. Specifically, a peptide which has an amino acid sequence of SEQ ID NO: 1 (AQTGTGKT) and thus binds to the CAGE protein is disclosed, which inhibits an inter-linkage between CAGE and GSK3?, thus exhibiting anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug resistant cancer cells. A pharmaceutical composition is also disclosed containing the peptide with the amino acid sequence of SEQ ID NO: 1 (AQTGTGKT), for anticancer use or anticancer drug aiding.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: March 26, 2019
    Assignee: L-BASE CO., LTD.
    Inventors: Doo Il Jeoung, Young Mi Kim, Hyun A Kim
  • Cage antigen
    Publication number: 20030092083
    Abstract: This invention relates to an isolated CAGE gene, which codes for a novel cancer/testis antigen expressed in various cancer cells. Various diagnostic and therapeutic uses arising out of the properties of the DNA and protein are part of this invention.
    Type: Application
    Filed: July 11, 2002
    Publication date: May 15, 2003
    Inventors: Doo-il Jeoung, Bomsoo Cho, Yoon Lim, Saeyoung Park, Daeyeon Lee, Yung-Jue Bang, Hankwang Yang, Dae-Kee Kim